|
US1019519A
(en)
|
1911-07-11 |
1912-03-05 |
Oscar Martin Polin |
Apparatus for making backing for teeth.
|
|
US4172896A
(en)
|
1978-06-05 |
1979-10-30 |
Dainippon Pharmaceutical Co., Ltd. |
Methane-sulfonamide derivatives, the preparation thereof and composition comprising the same
|
|
GB9217295D0
(en)
|
1992-08-14 |
1992-09-30 |
Wellcome Found |
Controlled released tablets
|
|
US5358970A
(en)
|
1993-08-12 |
1994-10-25 |
Burroughs Wellcome Co. |
Pharmaceutical composition containing bupropion hydrochloride and a stabilizer
|
|
US5541231A
(en)
|
1993-07-30 |
1996-07-30 |
Glaxo Wellcome Inc. |
Stabilized Pharmaceutical
|
|
GB9315856D0
(en)
|
1993-07-30 |
1993-09-15 |
Wellcome Found |
Stabilized pharmaceutical
|
|
DK1348427T3
(da)
|
1997-07-29 |
2008-06-30 |
Alcon Lab Inc |
Oftalmiske sammensætninger indeholdende galactomannanpolymerer og borater
|
|
US6110973A
(en)
|
1998-01-29 |
2000-08-29 |
Sepracor |
Methods for treating obesity and weight gain using optically pure (-)-bupropion
|
|
US8889112B2
(en)
|
1999-09-16 |
2014-11-18 |
Ocularis Pharma, Llc |
Ophthalmic formulations including selective alpha 1 antagonists
|
|
US6451828B1
(en)
|
2000-08-10 |
2002-09-17 |
Elan Pharmaceuticals, Inc. |
Selective inhibition of glutaminase by bis-thiadiazoles
|
|
WO2002076939A2
(en)
|
2001-02-05 |
2002-10-03 |
Exegenics Inc. |
Cysteine protease inhibitors
|
|
EP2260846B1
(en)
*
|
2003-03-27 |
2018-11-28 |
Lankenau Institute for Medical Research |
Novel methods for the treatment of cancer
|
|
US6933289B2
(en)
|
2003-07-01 |
2005-08-23 |
Allergan, Inc. |
Inhibition of irritating side effects associated with use of a topical ophthalmic medication
|
|
ES2593113T3
(es)
|
2003-08-07 |
2016-12-05 |
Allergan, Inc. |
Composiciones para el suministro de agentes terapéuticos en los ojos y métodos para obtener y usar los mismos
|
|
US20050059744A1
(en)
|
2003-09-12 |
2005-03-17 |
Allergan, Inc. |
Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions
|
|
EP1747282B1
(en)
|
2004-04-15 |
2011-06-08 |
University of Florida Research Foundation, Inc. |
Map-2 proteolytic breakdown products as diagnostic biomarkers for neural injury
|
|
EP2183232B1
(en)
|
2007-08-02 |
2013-03-06 |
Amgen, Inc |
Pi3 kinase modulators and methods of use
|
|
EP2227233B1
(en)
*
|
2007-11-30 |
2013-02-13 |
Newlink Genetics |
Ido inhibitors
|
|
EP2255818B1
(en)
|
2008-02-19 |
2018-08-22 |
Earnest Medicine Co., Ltd. |
Oral or enteral composition useful for recovery of physical functions
|
|
PL2389352T3
(pl)
*
|
2009-01-26 |
2019-10-31 |
Univ Pennsylvania |
Inhibitory arginazy oraz sposoby zastosowania
|
|
WO2011143160A2
(en)
|
2010-05-10 |
2011-11-17 |
The Johns Hopkins University |
Metabolic inhibitor against tumors having an idh mutation
|
|
WO2012006506A1
(en)
|
2010-07-09 |
2012-01-12 |
Massachusetts Institute Of Technology |
Metabolic gene, enzyme, and flux targets for cancer therapy
|
|
EP2640189A4
(en)
|
2010-11-18 |
2014-03-19 |
Deuteria Pharmaceuticals Inc |
3-deutero-pomalidomide
|
|
US8894970B2
(en)
*
|
2010-12-31 |
2014-11-25 |
Corridor Pharmaceuticals, Inc. |
Arginase inhibitors and methods of use thereof
|
|
CA2742342A1
(en)
|
2011-02-12 |
2012-08-12 |
Baylor Research Institute |
Msh3 expression status determines the responsiveness of cancer cells to the chemotherapeutic treatment with parp inhibitors and platinum drugs
|
|
FI20115876A0
(fi)
|
2011-09-06 |
2011-09-06 |
Turun Yliopisto |
Yhdistelmähoito
|
|
CN103030597B
(zh)
|
2011-09-30 |
2014-10-01 |
南昌滨西科技有限公司 |
肾脏型谷氨酰胺酶抑制剂及其制备方法和用途
|
|
AU2012326109A1
(en)
*
|
2011-10-19 |
2014-05-29 |
Mars, Incorporated |
Inhibitors of arginase and their therapeutic applications
|
|
US8604016B2
(en)
|
2011-11-21 |
2013-12-10 |
Calithera Biosciences Inc. |
Heterocyclic inhibitors of glutaminase
|
|
WO2013078123A1
(en)
*
|
2011-11-21 |
2013-05-30 |
Calithera Biosciences Inc. |
Heterocyclic inhibitors of glutaminase
|
|
US10138479B2
(en)
|
2012-05-24 |
2018-11-27 |
Dana-Farber Cancer Institute, Inc. |
Targeting the glutamine to pyruvate pathway for treatment of oncogenic Kras-associated cancer
|
|
WO2014039960A1
(en)
|
2012-09-10 |
2014-03-13 |
Celgene Corporation |
Methods for the treatment of locally advanced breast cancer
|
|
EP2895623B1
(en)
|
2012-09-17 |
2018-08-22 |
Agios Pharmaceuticals, Inc. |
Use of e-cadherin and vimentin for selection of treatment responsive patients
|
|
RS62447B1
(sr)
|
2012-11-16 |
2021-11-30 |
Calithera Biosciences Inc |
Heterociklični inhibitori glutaminaze
|
|
EP2922832B1
(en)
|
2012-11-21 |
2019-10-09 |
Agios Pharmaceuticals, Inc. |
Glutaminase inhibitors and methods of use
|
|
WO2014079011A1
(en)
|
2012-11-22 |
2014-05-30 |
Agios Pharmaceuticals, Inc. |
Heterocyclic compounds for inhibiting glutaminase and their methods of use
|
|
US9029531B2
(en)
|
2012-11-22 |
2015-05-12 |
Agios Pharmaceuticals, Inc. |
Compounds and their methods of use
|
|
CA2892817A1
(en)
*
|
2012-12-03 |
2014-06-12 |
Calithera Biosciences Inc. |
Treatment of cancer with heterocyclic inhibitors of glutaminase
|
|
JP6313415B2
(ja)
*
|
2013-03-15 |
2018-04-18 |
ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ |
Ｉｄｏ阻害剤
|
|
TWI660739B
(zh)
*
|
2013-10-25 |
2019-06-01 |
製藥公司 |
使用布魯頓氏酪胺酸激酶抑制劑之治療及免疫療法
|
|
WO2015061432A1
(en)
|
2013-10-25 |
2015-04-30 |
Calithera Biosciences, Inc. |
Treatment of viral infections with inhibitors of glutaminase
|
|
GB201322725D0
(en)
*
|
2013-12-20 |
2014-02-05 |
Immodulon Therapeutics Ltd |
Cancer therapy
|
|
US20170165364A1
(en)
*
|
2014-02-21 |
2017-06-15 |
Idac Theranostics, Inc. |
Therapeutic agent for solid cancer
|
|
EP3116872A4
(en)
|
2014-03-14 |
2017-08-30 |
Calithera Biosciences, Inc. |
Combination therapy with glutaminase inhibitors
|
|
US10221459B2
(en)
|
2014-05-13 |
2019-03-05 |
Case Western Reserve University |
Compositions and methods of treating cancer harboring PIKC3A mutations
|
|
KR20170012562A
(ko)
|
2014-06-13 |
2017-02-02 |
칼리테라 바이오사이언시즈 인코포레이티드 |
글루타미나제 억제제를 사용하는 병용 요법
|
|
WO2016004413A2
(en)
|
2014-07-03 |
2016-01-07 |
Board Of Regents, University Of Texas System |
Gls1 inhibitors for treating disease
|
|
WO2016004418A1
(en)
|
2014-07-03 |
2016-01-07 |
Board Of Regents, University Of Texas System |
Glutaminase inhibitor therapy
|
|
WO2016014890A1
(en)
|
2014-07-24 |
2016-01-28 |
Calithera Biosciences, Inc. |
Treatment of multiple myeloma with heterocyclic inhibitors of glutaminase
|
|
US10316030B2
(en)
|
2014-08-07 |
2019-06-11 |
Calithera Biosciences, Inc. |
Crystal forms of glutaminase inhibitors
|
|
WO2016054388A1
(en)
|
2014-10-03 |
2016-04-07 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Glutaminase inhibitors
|
|
WO2016077632A2
(en)
|
2014-11-13 |
2016-05-19 |
Buck Institute For Research On Aging |
Inhibition of proline catabolism for the treatment of cancer and other therapeutic applications
|
|
MX379263B
(es)
|
2015-03-30 |
2025-03-11 |
Calithera Biosciences Inc |
Uso de inhibidores de glutaminasa para el tratamiento o prevención de cáncer.
|
|
EA035354B1
(ru)
|
2015-04-06 |
2020-06-01 |
Калитера Байосайенсиз, Инк. |
Лечение рака легких ингибиторами глутаминазы
|
|
CA2994165A1
(en)
|
2015-07-31 |
2017-02-09 |
The Johns Hopkins University |
Methods for cancer and immunotherapy using glutamine analogues, including don
|
|
JP2018530550A
(ja)
|
2015-10-01 |
2018-10-18 |
ギリアド サイエンシズ， インコーポレイテッド |
癌を治療するためのｂｔｋ阻害剤とチェックポイント阻害剤との組合せ
|
|
EP3359150A4
(en)
|
2015-10-05 |
2019-11-06 |
Calithera Biosciences, Inc. |
COMBINATION THERAPY WITH GLUTAMINASE INHIBITORS AND IMMUNO-ONCOLOGICAL AGENTS
|
|
EA201892587A1
(ru)
|
2016-05-20 |
2019-04-30 |
Биохэйвен Фармасьютикал Холдинг Компани Лтд. |
Использование глутамат-модулирующих средств вместе с иммунотерапией для лечения рака
|
|
SG11201901389XA
(en)
|
2016-08-25 |
2019-03-28 |
Calithera Biosciences Inc |
Combination therapy with glutaminase inhibitors
|
|
JP2019524852A
(ja)
|
2016-08-25 |
2019-09-05 |
キャリセラ バイオサイエンシーズ， インコーポレイテッド |
グルタミナーゼ阻害剤を用いる併用療法
|
|
US20180055825A1
(en)
|
2016-08-25 |
2018-03-01 |
Yu Liang |
Treatment of cancer with inhibitors of glutaminase
|
|
AU2018231058A1
(en)
|
2017-03-10 |
2019-09-19 |
Calithera Biosciences, Inc. |
Combination therapy with glutaminase inhibitors
|
|
WO2019089952A1
(en)
*
|
2017-11-03 |
2019-05-09 |
Calithera Biosciences, Inc. |
Conjoint therapy with glutaminase inhibitors
|